8 patents
Utility
Recombinant Adeno-associated Virus Vectors
3 Mar 22
AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein are described.
Daniel McCoy, Garrett E. Berry
Filed: 20 Sep 21
Utility
Adeno-associated Virus Vectors for Treatment of Rett Syndrome
24 Feb 22
The disclosure provides nucleic acids (comprising AAV expression cassettes), AAV vectors, and compositions for use in methods for treating and/or delaying the onset of diseases associated with mutations in the mecp2 gene, such as Rett Syndrome.
Colin O'Banion
Filed: 19 Aug 21
Utility
Virus Vectors for Targeting Ophthalmic Tissues
2 Dec 21
The present disclosure provides AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein.
Daniel McCoy, Garrett E. Berry
Filed: 3 Apr 19
Utility
Antibody-evading Virus Vectors
2 Dec 21
The present disclosure provides AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the modified AAV capsid protein.
Daniel McCoy, Garrett E. Berry, James Kennon Smith
Filed: 3 Apr 19
Utility
Antibody-evading Virus Vectors
25 Nov 21
The present disclosure provides recombinant AAV capsid proteins comprising a modification in the amino acid sequence and virus vectors comprising the recombinant AAV capsid proteins.
Daniel McCoy, Garrett E. Berry
Filed: 3 Apr 19
Utility
Recombinant Viral Vectors and Nucleic Acids for Producing the Same
21 Oct 21
Described herein are nucleic acids, AAV transfer cassettes and plasmids used in the production of recombinant adeno-associated viral (rAAV) vectors.
Darby Thomas, David Dismuke
Filed: 21 May 21
Utility
Aav Transfer Cassette
6 May 21
Described herein are AAV transfer cassettes and plasmids used in the production of recombinant adeno-associated viral (rAAV) vectors.
David Dismuke
Filed: 16 Oct 20
Utility
Adeno-associated Viral Vectors for Treatment of Niemann-pick Disease Type-c
22 Apr 21
Provided herein are gene therapy compositions and methods for treating, preventing, and/or curing NPC1.
Daniel MCCOY, Garrett E. BERRY, David DISMUKE
Filed: 16 Oct 20
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first